105 related articles for article (PubMed ID: 18360689)
21. Molecular characterization of cytochrome P450 1A and 3A and the effects of perfluorooctanoic acid on their mRNA levels in rare minnow (Gobiocypris rarus) gills.
Liu Y; Wang J; Wei Y; Zhang H; Liu Y; Dai J
Aquat Toxicol; 2008 Jul; 88(3):183-90. PubMed ID: 18508136
[TBL] [Abstract][Full Text] [Related]
22. Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice.
Zhao Y; Tan YS; Haslam SZ; Yang C
Toxicol Sci; 2010 May; 115(1):214-24. PubMed ID: 20118188
[TBL] [Abstract][Full Text] [Related]
23. Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4α).
Scharmach E; Buhrke T; Lichtenstein D; Lampen A
Toxicol Lett; 2012 Jul; 212(2):106-12. PubMed ID: 22609092
[TBL] [Abstract][Full Text] [Related]
24. In vitro assessment of the cytotoxic and mutagenic potential of perfluorooctanoic acid.
Fernández Freire P; Pérez Martin JM; Herrero O; Peropadre A; de la Peña E; Hazen MJ
Toxicol In Vitro; 2008 Aug; 22(5):1228-33. PubMed ID: 18499391
[TBL] [Abstract][Full Text] [Related]
25. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin.
Gaetani S; Fu J; Cassano T; Dipasquale P; Romano A; Righetti L; Cianci S; Laconca L; Giannini E; Scaccianoce S; Mairesse J; Cuomo V; Piomelli D
J Neurosci; 2010 Jun; 30(24):8096-101. PubMed ID: 20554860
[TBL] [Abstract][Full Text] [Related]
26. [Effects of peroxisome proliferators PFOA on immune system of mice].
Yang J; Li A; Yang Q; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):157-60. PubMed ID: 16507247
[TBL] [Abstract][Full Text] [Related]
27. Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression.
Terrazzino S; Berto F; Dalle Carbonare M; Fabris M; Guiotto A; Bernardini D; Leon A
FASEB J; 2004 Oct; 18(13):1580-2. PubMed ID: 15289450
[TBL] [Abstract][Full Text] [Related]
28. Dermal penetration potential of perfluorooctanoic acid (PFOA) in human and mouse skin.
Franko J; Meade BJ; Frasch HF; Barbero AM; Anderson SE
J Toxicol Environ Health A; 2012; 75(1):50-62. PubMed ID: 22047163
[TBL] [Abstract][Full Text] [Related]
29. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
DeWitt JC; Williams WC; Creech NJ; Luebke RW
J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
[TBL] [Abstract][Full Text] [Related]
30. Differential gene expression profiling of the molar tooth germ in peroxisome proliferator-activated receptor-alpha (PPAR-alpha) knockout mouse and in wild-type mouse: molar tooth phenotype of PPAR-alpha knockout mouse.
Sehic A; Khuu C; Risnes S; Osmundsen H
Eur J Oral Sci; 2009 Apr; 117(2):93-104. PubMed ID: 19320717
[TBL] [Abstract][Full Text] [Related]
31. The dynamics of neuronal activation during food anticipation and feeding in the brain of food-entrained rats.
Poulin AM; Timofeeva E
Brain Res; 2008 Aug; 1227():128-41. PubMed ID: 18602903
[TBL] [Abstract][Full Text] [Related]
32. Perfluorooctanoic acid-induced toxicities in chicken embryo primary cardiomyocytes: Roles of PPAR alpha and Wnt5a/Frizzled2.
Lv N; Yuan J; Ji A; Shi L; Gao M; Cui L; Jiang Q
Toxicol Appl Pharmacol; 2019 Oct; 381():114716. PubMed ID: 31445018
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of hypothalamic CART mRNA in response to body weight change following different dietary interventions.
Yu Y; South T; Wang Q; Huang XF
Neurochem Int; 2008 Jun; 52(8):1422-30. PubMed ID: 18455834
[TBL] [Abstract][Full Text] [Related]
34. Centrally administered neuromedin S inhibits feeding behavior and gastroduodenal motility in mice.
Atsuchi K; Asakawa A; Ushikai M; Ataka K; Tanaka R; Kato I; Fujimiya M; Inui A
Horm Metab Res; 2010 Jun; 42(7):535-8. PubMed ID: 20352600
[TBL] [Abstract][Full Text] [Related]
35. Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha.
Abbott BD; Wolf CJ; Schmid JE; Das KP; Zehr RD; Helfant L; Nakayama S; Lindstrom AB; Strynar MJ; Lau C
Toxicol Sci; 2007 Aug; 98(2):571-81. PubMed ID: 17488742
[TBL] [Abstract][Full Text] [Related]
36. A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).
MacNeil J; Steenland NK; Shankar A; Ducatman A
Environ Res; 2009 Nov; 109(8):997-1003. PubMed ID: 19740462
[TBL] [Abstract][Full Text] [Related]
37. Emerging endocrine disrupters: perfluoroalkylated substances.
Jensen AA; Leffers H
Int J Androl; 2008 Apr; 31(2):161-9. PubMed ID: 18315716
[TBL] [Abstract][Full Text] [Related]
38. Effect of neuropeptide B on feeding behavior is influenced by endogenous corticotropin-releasing factor activities.
Aikawa S; Ishii M; Yanagisawa M; Sakakibara Y; Sakurai T
Regul Pept; 2008 Nov; 151(1-3):147-52. PubMed ID: 18760311
[TBL] [Abstract][Full Text] [Related]
39. Role of hypothalamic AMP-kinase in food intake regulation.
Minokoshi Y; Shiuchi T; Lee S; Suzuki A; Okamoto S
Nutrition; 2008 Sep; 24(9):786-90. PubMed ID: 18725075
[TBL] [Abstract][Full Text] [Related]
40. Hypothalamic neuronal histamine signaling in the estrogen deficiency-induced obesity.
Gotoh K; Masaki T; Chiba S; Higuchi K; Kakuma T; Shimizu H; Mori M; Sakata T; Yoshimatsu H
J Neurochem; 2009 Sep; 110(6):1796-805. PubMed ID: 19619143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
